Image: Dr. Mehran served as co-lead investigator on the groundbreaking "SELUTION4ISR Trial," with findings unveiled at the Transcatheter Cardiovascular Therapeutics Conference in 2025. Credit: Mount Sinai Health System A newly developed drug-coated balloon has shown results comparable to current standard treatments for patients experiencing coronary in-stent restenosis (ISR) who undergo repeat percutaneous coronary intervention (PCI). This important international study, led by a